Stifel Financial’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-38,262
Closed -$3.5M 3280
2023
Q2
$3.5M Sell
38,262
-736
-2% -$60.4K ﹤0.01% 1258
2023
Q1
$2.87M Buy
38,998
+2,808
+8% +$243K ﹤0.01% 1347
2022
Q4
$3.02M Sell
36,190
-3,317
-8% -$299K ﹤0.01% 1253
2022
Q3
$3.82M Sell
39,507
-883
-2% -$105K 0.01% 1071
2022
Q2
$4.25M Sell
40,390
-2,423
-6% -$310K 0.01% 1045
2022
Q1
$7.38M Buy
42,813
+1,978
+5% +$296K 0.01% 855
2021
Q4
$6.61M Buy
40,835
+12,712
+45% +$2.04M 0.01% 918
2021
Q3
$4.19M Buy
28,123
+12
+0% +$2.5K 0.01% 1119
2021
Q2
$6.88M Sell
28,111
-2,286
-8% -$600K 0.01% 860
2021
Q1
$8.05M Buy
30,397
+6,241
+26% +$1.76M 0.01% 749
2020
Q4
$7.09M Buy
24,156
+626
+3% +$161K 0.01% 715
2020
Q3
$5.56M Sell
23,530
-467
-2% -$106K 0.01% 726
2020
Q2
$4.76M Buy
23,997
+1,932
+9% +$360K 0.01% 742
2020
Q1
$4.04M Sell
22,065
-47
-0.2% -$8.36K 0.01% 738
2019
Q4
$3.73M Buy
22,112
+6,079
+38% +$904K 0.01% 997
2019
Q3
$2.1M Buy
16,033
+2,101
+15% +$274K 0.01% 1279
2019
Q2
$1.71M Buy
+13,932
New +$1.65M ﹤0.01% 1460

Other funds holding AMED

Stifel Financial's AMED Position: Q3 2023 in Review

Stifel Financial sold out of Amedisys (AMED) in Q3 2023, closing a stake of 38,262 shares — an estimated $3.5M sold.

Stifel Financial first reported a position in AMED in Q2 2019 and held it in 17 quarters. The position peaked at $8.05M in Q1 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Stifel Financial reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Stifel Financial sold 38,262 Amedisys shares in Q3 2023, an estimated $3.5M.
  • Stifel Financial first reported a position in Amedisys in Q2 2019 and held it in 17 quarters.
  • Stifel Financial's Amedisys position peaked at $8.05M in Q1 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.